Johannes A N Dorresteijn

Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score

Johannes A N Dorresteijn, Frank L.J. Visseren, Annemarie M.J. Wassink et al. · Heart · 2013 · 263 citations · Full text

Medicine, Cardiology, Clinical Epidemiology +16

Relation Between Blood Pressure and Vascular Events and Mortality in Patients With Manifest Vascular Disease

Johannes A N Dorresteijn, Yolanda van der Graaf, Wilko Spiering et al. · Hypertension · 2011 · 134 citations

Medicine, Cardiology, Clinical Sciences +14

Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors

Joanne M. de Laat, Emma Tham, Carolina R C Pieterman et al. · European Journal of Endocrinology · 2012 · 55 citations · Full text

Medicine, Endocrinology, Oncology +17

Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women

Rob C.M. van Kruijsdijk, Frank L.J. Visseren, Paul M. Ridker et al. · Heart · 2014 · 51 citations · Full text

Medicine, Pharmacology, Preventive Medicine +13

Differential effects of renin–angiotensin–aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension

Johannes A N Dorresteijn, Ilse M. Schrover, Frank L.J. Visseren et al. · Journal of Hypertension · 2012 · 50 citations

Pharmacy, Pharmacology, Pharmacotherapy +17